Label: MUCINEX- guaifenesin tablet, extended release
- NDC Code(s): 55154-4680-0
- Packager: Cardinal Health 107, LLC
- This is a repackaged label.
- Source NDC Code(s): 68084-572
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: New Drug Application
Drug Label Information
Updated June 14, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each extended-release bi-layer tablet)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- •
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- •
- cough accompanied by too much phlegm (mucus)
Stop use and ask a doctor if
- •
- cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
This Unit Dose package is not child resistant and is Intended for Institutional Use Only. KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
If dispensed for outpatient use, a child-resistant container should be utilized.
-
Directions
- •
- do not crush, chew, or break tablet
- •
- take with a full glass of water
- •
- this product can be administered without regard for the timing of meals
- •
- adults and children 12 years of age and over: 1 or 2 tablets every 12 hours. Do not exceed 4 tablets in 24 hours.
- •
- children under 12 years of age: do not use
- Other information
- Inactive ingredients
- Questions?
-
SPL UNCLASSIFIED SECTION
* The name MUCINEX® and associated trademarked items are used with permission by Reckitt Benckiser
The drug product contained in this package is from NDC # 63824-008 Reckitt Benckiser.
Packaged and Distributed by American Health Packaging, 2550 John Glenn Avenue, Suite A, Columbus, OH 43217
Americanhealthpackaging.com
An AmerisourceBergen Company
Distributed by:
Cardinal Health
Dublin, OH 43017
L5315882-10624
L5315882-20624
057201
5500408/0915 - Principal Display Panel
-
INGREDIENTS AND APPEARANCE
MUCINEX
guaifenesin tablet, extended releaseProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:55154-4680(NDC:68084-572) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 600 mg Inactive Ingredients Ingredient Name Strength CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: HHT01ZNK31) FD&C BLUE NO. 1 (UNII: H3R47K3TBD) ALUMINUM OXIDE (UNII: LMI26O6933) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2) Product Characteristics Color white (blue and white) Score no score Shape OVAL Size 16mm Flavor Imprint Code Mucinex;600 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:55154-4680-0 10 in 1 BAG 01/01/2016 1 1 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021282 01/01/2016 Labeler - Cardinal Health 107, LLC (118546603)